As ANG2 levels might be associated with liver functional reserve deterioration and treatment response, an evaluation of the baseline ANG2 level might be beneficial for patients with unresectable HCC for whom treatment with lenvatinib is planned. Here, ANGPT2 is linked to hepatocellular carcinoma.